BUTHIAZIDE\CANRENOATE: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
0
Deaths Reported
5
Hospitalizations
13
As Primary/Secondary Suspect
Active Ingredient: BUTHIAZIDE\CANRENOATE POTASSIUM ·
First Report: 20130904 · Latest Report: 20220423
What Are the Most Common BUTHIAZIDE\CANRENOATE Side Effects?
#1 Most Reported
Hyponatraemia
9 reports (69.2%)
#2 Most Reported
Asthenia
6 reports (46.2%)
#3 Most Reported
Hyperkalaemia
5 reports (38.5%)
All BUTHIAZIDE\CANRENOATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyponatraemia | 9 | 69.2% | 0 | 5 |
| Asthenia | 6 | 46.2% | 0 | 0 |
| Hyperkalaemia | 5 | 38.5% | 0 | 1 |
Who Reports BUTHIAZIDE\CANRENOATE Side Effects? Age & Gender Data
Gender: 83.3% female, 16.7% male. Average age: 82.2 years. Most reports from: IT. View detailed demographics →
Is BUTHIAZIDE\CANRENOATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 0 |
| 2018 | 2 | 0 | 1 |
| 2020 | 1 | 0 | 0 |
| 2021 | 3 | 0 | 0 |
| 2022 | 2 | 0 | 2 |
What Is BUTHIAZIDE\CANRENOATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 6 |
Official FDA Label for BUTHIAZIDE\CANRENOATE
Official prescribing information from the FDA-approved drug label.